0001209191-23-048615.txt : 20230907
0001209191-23-048615.hdr.sgml : 20230907
20230907162158
ACCESSION NUMBER: 0001209191-23-048615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230905
FILED AS OF DATE: 20230907
DATE AS OF CHANGE: 20230907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nuss John
CENTRAL INDEX KEY: 0001874108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 231242542
MAIL ADDRESS:
STREET 1: C/O VENTYX BIOSCIENCES, INC.
STREET 2: 332 ENCINITAS BLVD. SUITE 200
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-05
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001874108
Nuss John
C/O VENTYX BIOSCIENCES, INC.
12790 EL CAMINO REAL, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
Chief Scientific Officer
0
Common Stock
2023-09-05
4
M
0
10000
0.20
A
254815
D
Common Stock
2023-09-05
4
S
0
6991
32.2439
D
247824
D
Common Stock
2023-09-05
4
S
0
3009
33.4142
D
244815
D
Stock Option (right to buy)
0.20
2023-09-05
4
M
0
10000
0.00
D
2030-05-01
Common Stock
10000
6778
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
Represents the weighted average share price of an aggregate total of 6,991 shares sold in the price range of $31.97 to $32.935. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 3,009 shares sold in the price range of $32.98 to $33.9549. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 1, 2020.
/s/ Christopher Krueger, as Attorney-in-Fact
2023-09-07